KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTS · NASDAQ
Analyze with AI
4/30/2025
4/30/2024
4/30/2023
4/30/2021
Operating Activities
Net Income-$114-$94-$84-$34
Dep. & Amort.$8$12$5$0
Deferred Tax$0$0-$0$0
Stock-Based Comp.$24$1$1$2
Change in WC-$6$4$1-$0
Other Non-Cash$10$4$7$2
Operating Cash Flow-$78-$72-$70-$30
Investing Activities
PP&E Inv.-$24-$13-$15-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$23-$12-$15-$0
Financing Activities
Debt Repay.$0$6-$5$20
Stock Issued$216$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$2-$1-$1-$0
Other Fin. Act.$116$73$102$29
Financing Cash Flow$330$78$96$49
Forex Effect$0$0$0$0
Net Chg. in Cash$229-$7$11$19
Supplemental Information
Beg. Cash$9$15$4$6
End Cash$238$9$15$25
Free Cash Flow-$101-$85-$85-$30
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Financial Statements & Key Stats | AlphaPilot